1. Home
  2. AWH vs ISPC Comparison

AWH vs ISPC Comparison

Compare AWH & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWH
  • ISPC
  • Stock Information
  • Founded
  • AWH 1993
  • ISPC 2009
  • Country
  • AWH United States
  • ISPC United States
  • Employees
  • AWH N/A
  • ISPC N/A
  • Industry
  • AWH Medical/Dental Instruments
  • ISPC Precision Instruments
  • Sector
  • AWH Health Care
  • ISPC Health Care
  • Exchange
  • AWH Nasdaq
  • ISPC Nasdaq
  • Market Cap
  • AWH 1.6M
  • ISPC N/A
  • IPO Year
  • AWH N/A
  • ISPC 2021
  • Fundamental
  • Price
  • AWH $0.11
  • ISPC $1.15
  • Analyst Decision
  • AWH Buy
  • ISPC
  • Analyst Count
  • AWH 2
  • ISPC 0
  • Target Price
  • AWH $4.40
  • ISPC N/A
  • AVG Volume (30 Days)
  • AWH 12.9M
  • ISPC 59.9K
  • Earning Date
  • AWH 03-27-2025
  • ISPC 05-06-2025
  • Dividend Yield
  • AWH N/A
  • ISPC N/A
  • EPS Growth
  • AWH N/A
  • ISPC N/A
  • EPS
  • AWH N/A
  • ISPC N/A
  • Revenue
  • AWH $9,182,000.00
  • ISPC $10,390,702.00
  • Revenue This Year
  • AWH $11.87
  • ISPC $13.82
  • Revenue Next Year
  • AWH $79.10
  • ISPC $11.76
  • P/E Ratio
  • AWH N/A
  • ISPC N/A
  • Revenue Growth
  • AWH 0.31
  • ISPC 0.74
  • 52 Week Low
  • AWH $0.08
  • ISPC $1.09
  • 52 Week High
  • AWH $3.63
  • ISPC $11.80
  • Technical
  • Relative Strength Index (RSI)
  • AWH 29.83
  • ISPC 30.53
  • Support Level
  • AWH $0.12
  • ISPC $1.29
  • Resistance Level
  • AWH $0.36
  • ISPC $1.44
  • Average True Range (ATR)
  • AWH 0.03
  • ISPC 0.10
  • MACD
  • AWH 0.01
  • ISPC 0.01
  • Stochastic Oscillator
  • AWH 9.00
  • ISPC 16.67

About AWH Aspira Women's Health Inc.

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

Share on Social Networks: